{"first_name":"Michael","last_name":"D. Taylor","permalink":"michael-d-taylor","crunchbase_url":"http://www.crunchbase.com/person/michael-d-taylor","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Sat Nov 10 14:19:27 UTC 2012","updated_at":"Sat Nov 10 14:20:57 UTC 2012","overview":"<p>Michael D. Taylor joined Ensemble Therapeutics as President and CEO in July of 2007 with more than 20 years experience in the pharmaceutical industry.  Prior to joining Ensemble, Mike was Senior Vice President for Pfizer’s Global R&amp;D division responsible for global project and portfolio management.  In other positions with Pfizer (and previously Warner-Lambert/Parke-Davis), Mike led early and late-stage development projects across multiple therapeutic areas, including Lipitor® and Neurontin®.  His career includes extensive experience in drug discovery, licensing and business development, and managing R&amp;D alliances with pharmaceutical and biotech partners.  In addition to his R&amp;D experience he is active in investor development, government affairs and public policy affecting the pharmaceutical industry. Until 2003 he was Adjunct Professor of Medicinal Chemistry at the College of Pharmacy at the University of Michigan, where he was active in teaching medicinal chemistry and biopharmaceutics. Mike has authored or coauthored 65 manuscripts and published abstracts and holds 6 patents.</p>","image":{"available_sizes":[[[96,122],"assets/images/resized/0021/9825/219825v1-max-150x150.jpg"],[[96,122],"assets/images/resized/0021/9825/219825v1-max-250x250.jpg"],[[96,122],"assets/images/resized/0021/9825/219825v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"Ph.D.","subject":"Medicinal Chemistry","institution":"State University of New York","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"President and Chief Executive Officer","firm":{"name":"Ensemble Therapeutics","permalink":"ensemble-therapeutics","type_of_entity":"company","image":{"available_sizes":[[[150,36],"assets/images/resized/0021/8602/218602v1-max-150x150.jpg"],[[250,61],"assets/images/resized/0021/8602/218602v1-max-250x250.jpg"],[[302,74],"assets/images/resized/0021/8602/218602v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}